Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ladprao General Hospital PCLBKK:LPH-R 70 Days Sales Outstanding is 19.09 as of Jun. 2026, which is 13% below its 10-year median of 22.03. GuruFocus rates BKK:LPH-R with a GF Score™ of 70/100 and a GF Value™ of ฿4.62 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Ladprao General Hospital PCL ranks better than 80.88% on this metric.
The historical rank and industry rank for Ladprao General Hospital PCL's Days Sales Outstanding or its related term are showing as below:
BKK:LPH-R'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 18.55 Med: 22.03 Max: 27.29
Current: 20.25
During the past 13 years, Ladprao General Hospital PCL's highest Days Sales Outstanding was 27.29. The lowest was 18.55. And the median was 22.03.
BKK:LPH-R's Days Sales Outstanding is ranked better than 80.88% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 45.83
vs BKK:LPH-R: 20.25
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ladprao General Hospital PCL Days Sales Outstanding Chart
BKK:LPH-R vs HCA, THC, EHC: Days Sales Outstanding Comparison
For the Medical Care Facilities subindustry, Ladprao General Hospital PCL's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ladprao General Hospital PCL Days Sales Outstanding vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ladprao General Hospital PCL's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Ladprao General Hospital PCL's Days Sales Outstanding falls into.
Ladprao General Hospital PCL Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ladprao General Hospital PCL (BKK:LPH-R) has a Days Sales Outstanding of 19.09 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ladprao General Hospital PCL and its competitors. This is 13% below median its historical median of 22.03. Over the past decade, Ladprao General Hospital PCL's Days Sales Outstanding has ranged from 18.55 to 27.29. According to the industry distribution chart, Ladprao General Hospital PCL ranks #126 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 19.1%.
Is Ladprao General Hospital PCL's Days Sales Outstanding too high?
Ladprao General Hospital PCL's current Days Sales Outstanding of 19.09 is 13% below median its 10-year median of 22.03. Over the past 10 years, this metric has ranged from a low of 18.55 to a high of 27.29. The Healthcare Providers & Services industry median Days Sales Outstanding is 45.83. Ladprao General Hospital PCL's value of 19.09 is 58.3% below this industry median. Based on the distribution chart, Ladprao General Hospital PCL ranks #126 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ladprao General Hospital PCL has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ladprao General Hospital PCL's Days Sales Outstanding compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ladprao General Hospital PCL ranks #126 out of 659 companies for Days Sales Outstanding. This places Ladprao General Hospital PCL in the top 19% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 45.83. Ladprao General Hospital PCL's value of 19.09 is 58.3% below this benchmark. Historically, Ladprao General Hospital PCL's own Days Sales Outstanding has ranged from 18.55 to 27.29 over the past decade. While the company's 10-year median is 22.03 vs. the industry median of 45.83, Ladprao General Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Healthcare Providers & Services company?
The median Days Sales Outstanding among Healthcare Providers & Services companies is 45.83, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ladprao General Hospital PCL's current Days Sales Outstanding of 19.09 is 58.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Ladprao General Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Days Sales Outstanding is 45.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ladprao General Hospital PCL's current Days Sales Outstanding is 19.09, which is 13% below median its own 10-year median of 22.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ladprao General Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, Ladprao General Hospital PCL (BKK:LPH-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿4.62, compared to a current price of ฿3.58 — trading 22.6% below its estimated fair value. The current Days Sales Outstanding is 19.09, which is 13% below median its 10-year median of 22.03 and 58.3% below the Healthcare Providers & Services industry median of 45.83. Ladprao General Hospital PCL's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Ladprao General Hospital PCL (BKK:LPH-R), the current Days Sales Outstanding is 19.09 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ladprao General Hospital PCL (BKK:LPH-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ladprao General Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.58 is trading 22.6% below its estimated GF Value™ of ฿4.62.
GuruFocus considers Ladprao General Hospital PCL to be Modestly Undervalued.
Key valuation signals for BKK:LPH-R:
Days Sales Outstanding: 19.09 (13% below median its 10-year median of 22.03)
GF Value™: ฿4.62 vs. price of ฿3.58 (22.6% below fair value)
Industry Position: 58.3% below the Healthcare Providers & Services median (#126 of 659)
No single metric tells the full story. See the BKK:LPH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ladprao General Hospital PCL is principally engaged in the hospital business. It has two segments: Hospital, and Scientific testing &, Inspection & Quality System Certification. The Hospital segment includes hospital services, health care centers, and a service contract with the Social Security Office. The Scientific Testing & Inspection & Quality System Certification segment provides analytical and diagnostic services for food and agricultural, pharmaceutical, and environmental, covering product analysis, calibration of instruments, inspections, and certifications in accordance with quality systems and international standards. A majority of its revenue is generated from the Hospital segment. The company mainly operates in Thailand.
70GF Score
Get the complete analysis for BKK:LPH-R
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:LPH-R has been successfully added to your 
